{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 9,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 1
      },
      "2": {
        "core": 1,
        "branch": 1
      },
      "3": {
        "core": 1,
        "branch": 0
      },
      "4": {
        "core": 1,
        "branch": 1
      },
      "5": {
        "core": 1,
        "branch": 1
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A1 ∨ G)",
        "prover9_expression": "(uses(organization1, substance1) | successful_treatment(drug1))",
        "natural": "Either organization1 uses substance1 or drug1 provides a successful treatment."
      },
      {
        "id": "Rule2",
        "formal": "(A10 → (A9 → G))",
        "prover9_expression": "(effective(drug1) -> (treats(drug1, disease1) -> successful_treatment(drug1)))",
        "natural": "Provided that drug1 is effective, then whenever drug1 treats disease1, it results in a successful treatment."
      },
      {
        "id": "Rule3",
        "formal": "(A11 → A13)",
        "prover9_expression": "(phase1_trial(drug1) -> phase3_trial(drug1))",
        "natural": "In case drug1 is in phase1 trial, then it is also in phase3 trial."
      },
      {
        "id": "Rule4",
        "formal": "(A11 ∨ A12)",
        "prover9_expression": "(phase1_trial(drug1) | phase2_trial(drug1))",
        "natural": "Drug1 is in phase1 trial or drug1 is in phase2 trial."
      },
      {
        "id": "Rule5",
        "formal": "(A12 → A10)",
        "prover9_expression": "(phase2_trial(drug1) -> effective(drug1))",
        "natural": "Whenever drug1 is in phase2 trial, it implies that drug1 is effective."
      },
      {
        "id": "Rule6",
        "formal": "(A14 → (A13 → A10))",
        "prover9_expression": "(fda_approved(drug1) -> (phase3_trial(drug1) -> effective(drug1)))",
        "natural": "Given that drug1 is FDA approved, then if drug1 is in phase3 trial, drug1 is effective."
      },
      {
        "id": "Rule7",
        "formal": "(A16 → A15)",
        "prover9_expression": "(licensed(organization6) -> produces(organization6, drug2))",
        "natural": "Provided that organization6 is licensed, then organization6 produces drug2."
      },
      {
        "id": "Rule8",
        "formal": "(A16 ∨ A17)",
        "prover9_expression": "(licensed(organization6) | imports(organization7, drug2))",
        "natural": "Organization6 is licensed or organization7 imports drug2."
      },
      {
        "id": "Rule9",
        "formal": "(A18 → G)",
        "prover9_expression": "(approved(region2, drug2) -> successful_treatment(drug1))",
        "natural": "In the event that region2 has approved drug2, then drug1 provides a successful treatment."
      },
      {
        "id": "Rule10",
        "formal": "(A2 → ¬A1)",
        "prover9_expression": "(banned(region1, material1) -> -uses(organization1, substance1))",
        "natural": "Should region1 have banned material1, then organization1 does not use substance1."
      },
      {
        "id": "Rule11",
        "formal": "(A20 → (¬(A17 → A18) → A19))",
        "prover9_expression": "(monitors(fda, drug3) -> (-(imports(organization7, drug2) -> approved(region2, drug2)) -> counterfeit(drug2)))",
        "natural": "Whenever the FDA monitors drug3, then if it is not the case that imports by organization7 lead to approval by region2, drug2 is counterfeit."
      },
      {
        "id": "Rule12",
        "formal": "(A21 → A20)",
        "prover9_expression": "(investigates(fda, organization8) -> monitors(fda, drug3))",
        "natural": "Provided that the FDA investigates organization8, then the FDA monitors drug3."
      },
      {
        "id": "Rule13",
        "formal": "(A21 ∨ A22)",
        "prover9_expression": "(investigates(fda, organization8) | audits(fda, organization9))",
        "natural": "The FDA investigates organization8 or the FDA audits organization9."
      },
      {
        "id": "Rule14",
        "formal": "(A23 → (A22 → A20))",
        "prover9_expression": "(warning_letter(fda, organization8) -> (audits(fda, organization9) -> monitors(fda, drug3)))",
        "natural": "Given that the FDA issued a warning letter to organization8, then whenever the FDA audits organization9, the FDA monitors drug3."
      },
      {
        "id": "Rule15",
        "formal": "(A23 ∨ A24)",
        "prover9_expression": "(warning_letter(fda, organization8) | inspection(fda, organization9))",
        "natural": "Either the FDA issued a warning letter to organization8 or the FDA is conducting an inspection of organization9."
      },
      {
        "id": "Rule16",
        "formal": "(A24 → (A22 → A20))",
        "prover9_expression": "(inspection(fda, organization9) -> (audits(fda, organization9) -> monitors(fda, drug3)))",
        "natural": "Should the FDA be conducting an inspection of organization9, then if the FDA audits organization9, the FDA monitors drug3."
      },
      {
        "id": "Rule17",
        "formal": "(A26 → (¬G → ¬A25))",
        "prover9_expression": "(recalls(manufacturer1, drug4) -> (-successful_treatment(drug1) -> -side_effects(drug4)))",
        "natural": "Whenever manufacturer1 recalls drug4, then if drug1 does not provide a successful treatment, drug4 does not have side effects."
      },
      {
        "id": "Rule18",
        "formal": "(A31 → A30)",
        "prover9_expression": "(admits_fault(manufacturer1) -> settles(manufacturer1, lawsuit1))",
        "natural": "In case manufacturer1 admits fault, then manufacturer1 settles lawsuit1."
      },
      {
        "id": "Rule19",
        "formal": "(A31 ∨ A32)",
        "prover9_expression": "(admits_fault(manufacturer1) | denies_fault(manufacturer1))",
        "natural": "Manufacturer1 admits fault or manufacturer1 denies fault."
      },
      {
        "id": "Rule20",
        "formal": "(A32 → (¬(A28 → ¬A27) → A29))",
        "prover9_expression": "(denies_fault(manufacturer1) -> (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1)))",
        "natural": "Should manufacturer1 deny fault, then if contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1."
      },
      {
        "id": "Rule21",
        "formal": "(A35 → (¬(A33 → G) → ¬A34))",
        "prover9_expression": "(extends_patent(company1, drug5) -> (-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5)))",
        "natural": "Provided that company1 extends the patent for drug5, then if it is not the case that patenting leads to successful treatment, a generic version of drug5 is not available."
      },
      {
        "id": "Rule22",
        "formal": "(A37 → (¬A35 → ¬A36))",
        "prover9_expression": "(innovates(company1, drug6) -> (-extends_patent(company1, drug5) -> -competition(company2, drug5)))",
        "natural": "In the event that company1 innovates drug6, then should company1 not extend the patent for drug5, company2 does not compete with drug5."
      },
      {
        "id": "Rule23",
        "formal": "(A38 → (¬A35 → ¬A36))",
        "prover9_expression": "(acquires(company1, company3) -> (-extends_patent(company1, drug5) -> -competition(company2, drug5)))",
        "natural": "Whenever company1 acquires company3, then if company1 does not extend the patent for drug5, company2 does not compete with drug5."
      },
      {
        "id": "Rule24",
        "formal": "(A39 → (A37 ∨ A38))",
        "prover9_expression": "(researches(company1, disease2) -> (innovates(company1, drug6) | acquires(company1, company3)))",
        "natural": "Provided that company1 researches disease2, then either company1 innovates drug6 or company1 acquires company3."
      },
      {
        "id": "Rule25",
        "formal": "(A40 → ¬A3)",
        "prover9_expression": "(restricted(region3, material3) -> -approved(region1, material1))",
        "natural": "In case region3 has restricted material3, then region1 has not approved material1."
      },
      {
        "id": "Rule26",
        "formal": "(A41 → A42)",
        "prover9_expression": "(violates(company4, regulation1) -> compliant(company4))",
        "natural": "Should company4 violate regulation1, then company4 is compliant."
      },
      {
        "id": "Rule27",
        "formal": "(A41 → A43)",
        "prover9_expression": "(violates(company4, regulation1) -> fined(company4))",
        "natural": "Whenever company4 violates regulation1, then company4 is fined."
      },
      {
        "id": "Rule28",
        "formal": "(A44 → (A43 → ¬A42))",
        "prover9_expression": "(investigates(agency1, company4) -> (fined(company4) -> -compliant(company4)))",
        "natural": "Given that agency1 investigates company4, then if company4 is fined, company4 is not compliant."
      },
      {
        "id": "Rule29",
        "formal": "(A44 ∨ A45)",
        "prover9_expression": "(investigates(agency1, company4) | audits(agency2, company4))",
        "natural": "Agency1 investigates company4 or agency2 audits company4."
      },
      {
        "id": "Rule30",
        "formal": "(A46 → (A45 → (A43 → ¬A42)))",
        "prover9_expression": "(revokes_license(agency1, company4) -> (audits(agency2, company4) -> (fined(company4) -> -compliant(company4))))",
        "natural": "Provided that agency1 revokes the license of company4, then if agency2 audits company4 and company4 is fined, company4 is not compliant."
      },
      {
        "id": "Rule31",
        "formal": "(A46 ∨ A47)",
        "prover9_expression": "(revokes_license(agency1, company4) | suspends_license(agency2, company4))",
        "natural": "Either agency1 revokes the license of company4 or agency2 suspends the license of company4."
      },
      {
        "id": "Rule32",
        "formal": "(A47 → (A45 → (A43 → ¬A42)))",
        "prover9_expression": "(suspends_license(agency2, company4) -> (audits(agency2, company4) -> (fined(company4) -> -compliant(company4))))",
        "natural": "In case agency2 suspends the license of company4, then if agency2 audits company4 and company4 is fined, company4 is not compliant."
      },
      {
        "id": "Rule33",
        "formal": "(A49 → ¬A48)",
        "prover9_expression": "(experimental(drug7) -> -approved_therapy(drug7))",
        "natural": "Whenever drug7 is experimental, then drug7 is not an approved therapy."
      },
      {
        "id": "Rule34",
        "formal": "(A5 → A7)",
        "prover9_expression": "(develops(organization2, material2) -> tests(organization4, material2))",
        "natural": "In the event that organization2 develops material2, then organization4 tests material2."
      },
      {
        "id": "Rule35",
        "formal": "(A5 ∨ A6)",
        "prover9_expression": "(develops(organization2, material2) | imports(organization3, material2))",
        "natural": "Organization2 develops material2 or organization3 imports material2."
      },
      {
        "id": "Rule36",
        "formal": "(A51 → ¬A50)",
        "prover9_expression": "(expensive(drug7) -> -covered(insurance1, drug7))",
        "natural": "Should drug7 be expensive, then insurance1 does not cover drug7."
      },
      {
        "id": "Rule37",
        "formal": "(A52 ∨ (¬A49 → A51))",
        "prover9_expression": "(reimbursed(medicare, drug7) | (-experimental(drug7) -> expensive(drug7)))",
        "natural": "Medicare reimburses for drug7 or, if drug7 is not experimental, then drug7 is expensive."
      },
      {
        "id": "Rule38",
        "formal": "(A53 → ¬A52)",
        "prover9_expression": "(rejected(fda, drug8) -> -reimbursed(medicare, drug7))",
        "natural": "Provided that the FDA rejected drug8, then Medicare does not reimburse for drug7."
      },
      {
        "id": "Rule39",
        "formal": "(A56 ∨ (A55 ∨ (A54 → (¬(A28 → ¬A27) → A29))))",
        "prover9_expression": "(litigates(company5, fda) | (appeals(company5, decision1) | (resubmits(company5, drug8) -> (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1)))))",
        "natural": "Company5 litigates against the FDA or company5 appeals decision1 or, if company5 resubmits drug8, then whenever contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1."
      },
      {
        "id": "Rule40",
        "formal": "(A57 → ¬A56)",
        "prover9_expression": "(withdraws(company5, drug8) -> -litigates(company5, fda))",
        "natural": "In case company5 withdraws drug8, then company5 does not litigate against the FDA."
      },
      {
        "id": "Rule41",
        "formal": "(A59 ∨ (¬A57 → ¬A58))",
        "prover9_expression": "(develops_alternative(company5, drug9) | (-withdraws(company5, drug8) -> -continues_research(company5, drug8)))",
        "natural": "Company5 develops an alternative, drug9 or, provided that company5 does not withdraw drug8, then company5 does not continue research on drug8."
      },
      {
        "id": "Rule42",
        "formal": "(A6 → (¬(¬A2 → ¬A3) → ¬A4))",
        "prover9_expression": "(imports(organization3, material2) -> (-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1)))",
        "natural": "Should organization3 import material2, then if it is not the case that banning by region1 implies non-approval by region1, material1 is not safe."
      },
      {
        "id": "Rule43",
        "formal": "(A61 → A60)",
        "prover9_expression": "(successful(drug10) -> profitable(drug10))",
        "natural": "Whenever drug10 is successful, then drug10 is profitable."
      },
      {
        "id": "Rule44",
        "formal": "(A65 ∨ (¬(¬(A62 → A61) → A63) → A64))",
        "prover9_expression": "(relaunched(drug10) | (-(-(blockbuster(drug10) -> successful(drug10)) -> niche(drug10)) -> discontinued(drug10)))",
        "natural": "Drug10 is relaunched or, if it is not the case that blockbuster status implies success and then niche status, then drug10 is discontinued."
      },
      {
        "id": "Rule45",
        "formal": "(A7 → A8)",
        "prover9_expression": "(tests(organization4, material2) -> manufactures(organization5, material2))",
        "natural": "Provided that organization4 tests material2, then organization5 manufactures material2."
      },
      {
        "id": "Rule46",
        "formal": "(A8 → (¬(¬A2 → ¬A3) → ¬A4))",
        "prover9_expression": "(manufactures(organization5, material2) -> (-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1)))",
        "natural": "Whenever organization5 manufactures material2, then if it is not the case that banning by region1 implies non-approval by region1, material1 is not safe."
      },
      {
        "id": "Rule47",
        "formal": "(¬(A28 → ¬A27) → ¬A29)",
        "prover9_expression": "(-(contaminated(drug4) -> -defective(drug4)) -> -lawsuit(patient1, manufacturer1))",
        "natural": "Should contamination not imply non-defectiveness, then patient1 did not file a lawsuit against manufacturer1."
      },
      {
        "id": "Rule48",
        "formal": "(¬(A33 → G) → A34)",
        "prover9_expression": "(-(patented(drug5) -> successful_treatment(drug1)) -> generic_available(drug5))",
        "natural": "Whenever it is not the case that patenting leads to successful treatment, then a generic version of drug5 is available."
      },
      {
        "id": "Rule49",
        "formal": "(¬(A62 → A61) → ¬A63)",
        "prover9_expression": "(-(blockbuster(drug10) -> successful(drug10)) -> -niche(drug10))",
        "natural": "Should it not be true that blockbuster status leads to success, then drug10 is not niche."
      },
      {
        "id": "Rule50",
        "formal": "(¬(¬(A33 → G) → ¬A34) → A62)",
        "prover9_expression": "(-(-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5)) -> blockbuster(drug10))",
        "natural": "Provided that it is not the case that non-patenting implies non-generic availability, then drug10 is a blockbuster."
      },
      {
        "id": "Rule51",
        "formal": "(¬(¬A2 → A40) → A41)",
        "prover9_expression": "(-(-banned(region1, material1) -> restricted(region3, material3)) -> violates(company4, regulation1))",
        "natural": "In the event that it is not the case that non-banning by region1 leads to restriction by region3, then company4 violates regulation1."
      },
      {
        "id": "Rule52",
        "formal": "(¬(¬A2 → ¬A3) → A4)",
        "prover9_expression": "(-(-banned(region1, material1) -> -approved(region1, material1)) -> safe(material1))",
        "natural": "Provided that it is not true that non-banning implies non-approval by region1, then material1 is safe."
      },
      {
        "id": "Rule53",
        "formal": "(¬A10 → A48)",
        "prover9_expression": "(-effective(drug1) -> approved_therapy(drug7))",
        "natural": "Should drug1 not be effective, then drug7 is an approved therapy."
      },
      {
        "id": "Rule54",
        "formal": "(¬A2 → A3)",
        "prover9_expression": "(-banned(region1, material1) -> approved(region1, material1))",
        "natural": "In case region1 has not banned material1, then region1 has approved material1."
      },
      {
        "id": "Rule55",
        "formal": "(¬A26 → A27)",
        "prover9_expression": "(-recalls(manufacturer1, drug4) -> defective(drug4))",
        "natural": "Should manufacturer1 not recall drug4, then drug4 is defective."
      },
      {
        "id": "Rule56",
        "formal": "(¬A26 → A28)",
        "prover9_expression": "(-recalls(manufacturer1, drug4) -> contaminated(drug4))",
        "natural": "In the event that manufacturer1 does not recall drug4, then drug4 is contaminated."
      },
      {
        "id": "Rule57",
        "formal": "(¬A35 → A36)",
        "prover9_expression": "(-extends_patent(company1, drug5) -> competition(company2, drug5))",
        "natural": "Whenever company1 does not extend the patent for drug5, then company2 competes with drug5."
      },
      {
        "id": "Rule58",
        "formal": "(¬A49 → A50)",
        "prover9_expression": "(-experimental(drug7) -> covered(insurance1, drug7))",
        "natural": "Should drug7 not be experimental, then insurance1 covers drug7."
      },
      {
        "id": "Rule59",
        "formal": "(¬A57 → A58)",
        "prover9_expression": "(-withdraws(company5, drug8) -> continues_research(company5, drug8))",
        "natural": "In the event that company5 does not withdraw drug8, then company5 continues research on drug8."
      },
      {
        "id": "Rule60",
        "formal": "(¬G → A25)",
        "prover9_expression": "(-successful_treatment(drug1) -> side_effects(drug4))",
        "natural": "Provided that drug1 does not provide a successful treatment, then drug4 has side effects."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A14",
        "prover9_expression": "fda_approved(drug1)",
        "natural": "Drug1 is FDA approved."
      },
      {
        "id": "Fact2",
        "formal": "A33",
        "prover9_expression": "patented(drug5)",
        "natural": "Drug5 is patented."
      },
      {
        "id": "Fact3",
        "formal": "A39",
        "prover9_expression": "researches(company1, disease2)",
        "natural": "Company1 researches disease2."
      },
      {
        "id": "Fact4",
        "formal": "A53",
        "prover9_expression": "rejected(fda, drug8)",
        "natural": "The FDA rejected drug8."
      },
      {
        "id": "Fact5",
        "formal": "A54",
        "prover9_expression": "resubmits(company5, drug8)",
        "natural": "Company5 resubmits drug8."
      },
      {
        "id": "Fact6",
        "formal": "A9",
        "prover9_expression": "treats(drug1, disease1)",
        "natural": "Drug1 treats disease1."
      },
      {
        "id": "Fact7",
        "formal": "¬A15",
        "prover9_expression": "-produces(organization6, drug2)",
        "natural": "Organization6 does not produce drug2."
      },
      {
        "id": "Fact8",
        "formal": "¬A19",
        "prover9_expression": "-counterfeit(drug2)",
        "natural": "Drug2 is not counterfeit."
      },
      {
        "id": "Fact9",
        "formal": "¬A30",
        "prover9_expression": "-settles(manufacturer1, lawsuit1)",
        "natural": "Manufacturer1 does not settle lawsuit1."
      },
      {
        "id": "Fact10",
        "formal": "¬A55",
        "prover9_expression": "-appeals(company5, decision1)",
        "natural": "Company5 does not appeal decision1."
      },
      {
        "id": "Fact11",
        "formal": "¬A59",
        "prover9_expression": "-develops_alternative(company5, drug9)",
        "natural": "Company5 does not develop an alternative, drug9."
      },
      {
        "id": "Fact12",
        "formal": "¬A60",
        "prover9_expression": "-profitable(drug10)",
        "natural": "Drug10 is not profitable."
      },
      {
        "id": "Fact13",
        "formal": "¬A64",
        "prover9_expression": "-discontinued(drug10)",
        "natural": "Drug10 is not discontinued."
      },
      {
        "id": "Fact14",
        "formal": "¬A65",
        "prover9_expression": "-relaunched(drug10)",
        "natural": "Drug10 is not relaunched."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "successful_treatment(drug1)",
    "natural": "Drug1 provides a successful treatment."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A7 -> A8)",
            "(A8 -> (-(-A2 -> -A3) -> -A4))"
          ],
          "conclusion": "(A7 -> (-(-A2 -> -A3) -> -A4))",
          "natural": "In the event that organization4 tests material2, then should it not be the case that banning by region1 implies non-approval by region1, material1 is not safe."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A5 -> A7)",
            "(A7 -> (-(-A2 -> -A3) -> -A4))"
          ],
          "conclusion": "(A5 -> (-(-A2 -> -A3) -> -A4))",
          "natural": "Provided that organization2 develops material2, then if it is not the case that banning by region1 implies non-approval by region1, material1 is not safe."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A5 | A6)",
            "(A5 -> (-(-A2 -> -A3) -> -A4))",
            "(A6 -> (-(-A2 -> -A3) -> -A4))"
          ],
          "conclusion": "(-(-A2 -> -A3) -> -A4)",
          "natural": "Whenever it is not the case that non-banning leads to non-approval by region1, then material1 is not safe."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-A2 -> -A3) -> A4)",
            "(-(-A2 -> -A3) -> -A4)"
          ],
          "conclusion": "(-A2 -> -A3)",
          "natural": "Whenever region1 has not banned material1, then region1 has not approved material1."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A2 -> A3)",
            "(-A2 -> -A3)"
          ],
          "conclusion": "A2",
          "natural": "Region1 has banned material1."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A2 -> -A1)",
            "A2"
          ],
          "conclusion": "-A1",
          "natural": "Organization1 does not use substance1."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "Drug1 provides a successful treatment."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A14 -> (A13 -> A10))",
            "A14"
          ],
          "conclusion": "(A13 -> A10)",
          "natural": "Should drug1 be in phase3 trial, then drug1 is effective."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A11 -> A13)",
            "(A13 -> A10)"
          ],
          "conclusion": "(A11 -> A10)",
          "natural": "If drug1 is in phase1 trial, then drug1 is effective."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A11 | A12)",
            "(A11 -> A10)",
            "(A12 -> A10)"
          ],
          "conclusion": "A10",
          "natural": "Drug1 is effective."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A10 -> (A9 -> G))",
            "A10"
          ],
          "conclusion": "(A9 -> G)",
          "natural": "Should drug1 treat disease1, then drug1 provides a successful treatment."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A9 -> G)",
            "A9"
          ],
          "conclusion": "G",
          "natural": "Drug1 provides a successful treatment."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A23 | A24)",
            "(A23 -> (A22 -> A20))",
            "(A24 -> (A22 -> A20))"
          ],
          "conclusion": "(A22 -> A20)",
          "natural": "In case the FDA audits organization9, then the FDA monitors drug3."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A21 | A22)",
            "(A21 -> A20)",
            "(A22 -> A20)"
          ],
          "conclusion": "A20",
          "natural": "The FDA monitors drug3."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A20 -> (-(A17 -> A18) -> A19))",
            "A20"
          ],
          "conclusion": "(-(A17 -> A18) -> A19)",
          "natural": "In case it is not true that imports by organization7 lead to approval by region2, then drug2 is counterfeit."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A17 -> A18) -> A19)",
            "-A19"
          ],
          "conclusion": "(A17 -> A18)",
          "natural": "Whenever organization7 imports drug2, it follows that region2 has approved drug2."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(A17 -> A18)",
            "(A18 -> G)"
          ],
          "conclusion": "(A17 -> G)",
          "natural": "If organization7 imports drug2, then drug1 provides a successful treatment."
        },
        {
          "step_number": 6,
          "rule_applied": "CD",
          "premises_used": [
            "(A16 -> A15)",
            "(A17 -> G)",
            "(A16 | A17)"
          ],
          "conclusion": "(A15 | G)",
          "natural": "Either organization6 produces drug2 or drug1 provides a successful treatment."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A15 | G)",
            "-A15"
          ],
          "conclusion": "G",
          "natural": "Drug1 provides a successful treatment."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "CD",
          "premises_used": [
            "(A31 -> A30)",
            "(A32 -> (-(A28 -> -A27) -> A29))",
            "(A31 | A32)"
          ],
          "conclusion": "(A30 | (-(A28 -> -A27) -> A29))",
          "natural": "Manufacturer1 settles lawsuit1 or, if it is not the case that contamination implies non-defectiveness, then patient1 filed a lawsuit against manufacturer1."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A30 | (-(A28 -> -A27) -> A29))",
            "-A30"
          ],
          "conclusion": "(-(A28 -> -A27) -> A29)",
          "natural": "Provided that contamination does not imply non-defectiveness, then patient1 filed a lawsuit against manufacturer1."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A28 -> -A27) -> A29)",
            "(-(A28 -> -A27) -> -A29)"
          ],
          "conclusion": "(A28 -> -A27)",
          "natural": "Provided that drug4 is contaminated, then drug4 is not defective."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(-A26 -> A28)",
            "(A28 -> -A27)"
          ],
          "conclusion": "(-A26 -> -A27)",
          "natural": "Provided that manufacturer1 does not recall drug4, then drug4 is not defective."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A26 -> A27)",
            "(-A26 -> -A27)"
          ],
          "conclusion": "A26",
          "natural": "Manufacturer1 recalls drug4."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A26 -> (-G -> -A25))",
            "A26"
          ],
          "conclusion": "(-G -> -A25)",
          "natural": "Whenever drug1 does not provide a successful treatment, then drug4 does not have side effects."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A25)",
            "(-G -> -A25)"
          ],
          "conclusion": "G",
          "natural": "Drug1 provides a successful treatment."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 5,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A39 -> (A37 | A38))",
            "A39"
          ],
          "conclusion": "(A37 | A38)",
          "natural": "Company1 innovates drug6 or company1 acquires company3."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A37 | A38)",
            "(A37 -> (-A35 -> -A36))",
            "(A38 -> (-A35 -> -A36))"
          ],
          "conclusion": "(-A35 -> -A36)",
          "natural": "In case company1 does not extend the patent for drug5, then company2 does not compete with drug5."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A35 -> A36)",
            "(-A35 -> -A36)"
          ],
          "conclusion": "A35",
          "natural": "Company1 extends the patent for drug5."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A35 -> (-(A33 -> G) -> -A34))",
            "A35"
          ],
          "conclusion": "(-(A33 -> G) -> -A34)",
          "natural": "In the event that it is not true that patenting implies successful treatment, then a generic version of drug5 is not available."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A33 -> G) -> A34)",
            "(-(A33 -> G) -> -A34)"
          ],
          "conclusion": "(A33 -> G)",
          "natural": "Whenever drug5 is patented, then drug1 provides a successful treatment."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A33 -> G)",
            "A33"
          ],
          "conclusion": "G",
          "natural": "Drug1 provides a successful treatment."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A46 | A47)",
            "(A46 -> (A45 -> (A43 -> -A42)))",
            "(A47 -> (A45 -> (A43 -> -A42)))"
          ],
          "conclusion": "(A45 -> (A43 -> -A42))",
          "natural": "Should agency2 audit company4, then whenever company4 is fined, company4 is not compliant."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A44 | A45)",
            "(A44 -> (A43 -> -A42))",
            "(A45 -> (A43 -> -A42))"
          ],
          "conclusion": "(A43 -> -A42)",
          "natural": "In the event that company4 is fined, then company4 is not compliant."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A41 -> A43)",
            "(A43 -> -A42)"
          ],
          "conclusion": "(A41 -> -A42)",
          "natural": "Provided that company4 violates regulation1, then company4 is not compliant."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(A41 -> A42)",
            "(A41 -> -A42)"
          ],
          "conclusion": "-A41",
          "natural": "Company4 does not violate regulation1."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-A2 -> A40) -> A41)",
            "-A41"
          ],
          "conclusion": "(-A2 -> A40)",
          "natural": "Provided that region1 has not banned material1, then region3 has restricted material3."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            "(-A2 -> A40)",
            "(A40 -> -A3)"
          ],
          "conclusion": "(-A2 -> -A3)",
          "natural": "Whenever region1 has not banned material1, then region1 has not approved material1."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A2 -> A3)",
            "(-A2 -> -A3)"
          ],
          "conclusion": "A2",
          "natural": "Region1 has banned material1."
        },
        {
          "step_number": 8,
          "rule_applied": "MP",
          "premises_used": [
            "(A2 -> -A1)",
            "A2"
          ],
          "conclusion": "-A1",
          "natural": "Organization1 does not use substance1."
        },
        {
          "step_number": 9,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "Drug1 provides a successful treatment."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A53 -> -A52)",
            "A53"
          ],
          "conclusion": "-A52",
          "natural": "Medicare does not reimburse for drug7."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A52 | (-A49 -> A51))",
            "-A52"
          ],
          "conclusion": "(-A49 -> A51)",
          "natural": "Provided that drug7 is not experimental, then drug7 is expensive."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-A49 -> A51)",
            "(A51 -> -A50)"
          ],
          "conclusion": "(-A49 -> -A50)",
          "natural": "Whenever drug7 is not experimental, then insurance1 does not cover drug7."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A49 -> A50)",
            "(-A49 -> -A50)"
          ],
          "conclusion": "A49",
          "natural": "Drug7 is experimental."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A49 -> -A48)",
            "A49"
          ],
          "conclusion": "-A48",
          "natural": "Drug7 is not an approved therapy."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            "(-A10 -> A48)",
            "-A48"
          ],
          "conclusion": "A10",
          "natural": "Drug1 is effective."
        },
        {
          "step_number": 7,
          "rule_applied": "MP",
          "premises_used": [
            "(A10 -> (A9 -> G))",
            "A10"
          ],
          "conclusion": "(A9 -> G)",
          "natural": "Should drug1 treat disease1, then drug1 provides a successful treatment."
        },
        {
          "step_number": 8,
          "rule_applied": "MP",
          "premises_used": [
            "(A9 -> G)",
            "A9"
          ],
          "conclusion": "G",
          "natural": "Drug1 provides a successful treatment."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A59 | (-A57 -> -A58))",
            "-A59"
          ],
          "conclusion": "(-A57 -> -A58)",
          "natural": "Should company5 not withdraw drug8, then company5 does not continue research on drug8."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A57 -> A58)",
            "(-A57 -> -A58)"
          ],
          "conclusion": "A57",
          "natural": "Company5 withdraws drug8."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A57 -> -A56)",
            "A57"
          ],
          "conclusion": "-A56",
          "natural": "Company5 does not litigate against the FDA."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A56 | (A55 | (A54 -> (-(A28 -> -A27) -> A29))))",
            "-A56"
          ],
          "conclusion": "(A55 | (A54 -> (-(A28 -> -A27) -> A29)))",
          "natural": "Company5 appeals decision1 or, should company5 resubmit drug8, then if contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A55 | (A54 -> (-(A28 -> -A27) -> A29)))",
            "-A55"
          ],
          "conclusion": "(A54 -> (-(A28 -> -A27) -> A29))",
          "natural": "Whenever company5 resubmits drug8, then if contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A54 -> (-(A28 -> -A27) -> A29))",
            "A54"
          ],
          "conclusion": "(-(A28 -> -A27) -> A29)",
          "natural": "Provided that contamination does not imply non-defectiveness, then patient1 filed a lawsuit against manufacturer1."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A28 -> -A27) -> A29)",
            "(-(A28 -> -A27) -> -A29)"
          ],
          "conclusion": "(A28 -> -A27)",
          "natural": "Provided that drug4 is contaminated, then drug4 is not defective."
        },
        {
          "step_number": 8,
          "rule_applied": "HS",
          "premises_used": [
            "(-A26 -> A28)",
            "(A28 -> -A27)"
          ],
          "conclusion": "(-A26 -> -A27)",
          "natural": "Provided that manufacturer1 does not recall drug4, then drug4 is not defective."
        },
        {
          "step_number": 9,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A26 -> A27)",
            "(-A26 -> -A27)"
          ],
          "conclusion": "A26",
          "natural": "Manufacturer1 recalls drug4."
        },
        {
          "step_number": 10,
          "rule_applied": "MP",
          "premises_used": [
            "(A26 -> (-G -> -A25))",
            "A26"
          ],
          "conclusion": "(-G -> -A25)",
          "natural": "Whenever drug1 does not provide a successful treatment, then drug4 does not have side effects."
        },
        {
          "step_number": 11,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A25)",
            "(-G -> -A25)"
          ],
          "conclusion": "G",
          "natural": "Drug1 provides a successful treatment."
        }
      ]
    },
    {
      "id": 9,
      "family_id": 5,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A65 | (-(-(A62 -> A61) -> A63) -> A64))",
            "-A65"
          ],
          "conclusion": "(-(-(A62 -> A61) -> A63) -> A64)",
          "natural": "Should it not be true that non-blockbuster status implies non-niche status, then drug10 is discontinued."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-(A62 -> A61) -> A63) -> A64)",
            "-A64"
          ],
          "conclusion": "(-(A62 -> A61) -> A63)",
          "natural": "Provided that it is not the case that blockbuster status implies success, then drug10 is niche."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A62 -> A61) -> A63)",
            "(-(A62 -> A61) -> -A63)"
          ],
          "conclusion": "(A62 -> A61)",
          "natural": "Provided that drug10 is a blockbuster, then drug10 is successful."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(A33 -> G) -> -A34) -> A62)",
            "(A62 -> A61)"
          ],
          "conclusion": "(-(-(A33 -> G) -> -A34) -> A61)",
          "natural": "Whenever it is not true that non-patenting leads to non-generic availability, then drug10 is successful."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(A33 -> G) -> -A34) -> A61)",
            "(A61 -> A60)"
          ],
          "conclusion": "(-(-(A33 -> G) -> -A34) -> A60)",
          "natural": "In case it is not the case that non-patenting implies non-generic availability, then drug10 is profitable."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-(A33 -> G) -> -A34) -> A60)",
            "-A60"
          ],
          "conclusion": "(-(A33 -> G) -> -A34)",
          "natural": "In the event that it is not true that patenting implies successful treatment, then a generic version of drug5 is not available."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A33 -> G) -> A34)",
            "(-(A33 -> G) -> -A34)"
          ],
          "conclusion": "(A33 -> G)",
          "natural": "Whenever drug5 is patented, then drug1 provides a successful treatment."
        },
        {
          "step_number": 8,
          "rule_applied": "MP",
          "premises_used": [
            "(A33 -> G)",
            "A33"
          ],
          "conclusion": "G",
          "natural": "Drug1 provides a successful treatment."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Manufacturing",
    "atomic_facts": {
      "A1": "uses(organization1, substance1)",
      "A2": "banned(region1, material1)",
      "A3": "approved(region1, material1)",
      "A4": "safe(material1)",
      "A5": "develops(organization2, material2)",
      "A6": "imports(organization3, material2)",
      "A7": "tests(organization4, material2)",
      "A8": "manufactures(organization5, material2)",
      "A9": "treats(drug1, disease1)",
      "A10": "effective(drug1)",
      "A11": "phase1_trial(drug1)",
      "A12": "phase2_trial(drug1)",
      "A13": "phase3_trial(drug1)",
      "A14": "fda_approved(drug1)",
      "A15": "produces(organization6, drug2)",
      "A16": "licensed(organization6)",
      "A17": "imports(organization7, drug2)",
      "A18": "approved(region2, drug2)",
      "A19": "counterfeit(drug2)",
      "A20": "monitors(fda, drug3)",
      "A21": "investigates(fda, organization8)",
      "A22": "audits(fda, organization9)",
      "A23": "warning_letter(fda, organization8)",
      "A24": "inspection(fda, organization9)",
      "A25": "side_effects(drug4)",
      "A26": "recalls(manufacturer1, drug4)",
      "A27": "defective(drug4)",
      "A28": "contaminated(drug4)",
      "A29": "lawsuit(patient1, manufacturer1)",
      "A30": "settles(manufacturer1, lawsuit1)",
      "A31": "admits_fault(manufacturer1)",
      "A32": "denies_fault(manufacturer1)",
      "A33": "patented(drug5)",
      "A34": "generic_available(drug5)",
      "A35": "extends_patent(company1, drug5)",
      "A36": "competition(company2, drug5)",
      "A37": "innovates(company1, drug6)",
      "A38": "acquires(company1, company3)",
      "A39": "researches(company1, disease2)",
      "A40": "restricted(region3, material3)",
      "A41": "violates(company4, regulation1)",
      "A42": "compliant(company4)",
      "A43": "fined(company4)",
      "A44": "investigates(agency1, company4)",
      "A45": "audits(agency2, company4)",
      "A46": "revokes_license(agency1, company4)",
      "A47": "suspends_license(agency2, company4)",
      "A48": "approved_therapy(drug7)",
      "A49": "experimental(drug7)",
      "A50": "covered(insurance1, drug7)",
      "A51": "expensive(drug7)",
      "A52": "reimbursed(medicare, drug7)",
      "A53": "rejected(fda, drug8)",
      "A54": "resubmits(company5, drug8)",
      "A55": "appeals(company5, decision1)",
      "A56": "litigates(company5, fda)",
      "A57": "withdraws(company5, drug8)",
      "A58": "continues_research(company5, drug8)",
      "A59": "develops_alternative(company5, drug9)",
      "A60": "profitable(drug10)",
      "A61": "successful(drug10)",
      "A62": "blockbuster(drug10)",
      "A63": "niche(drug10)",
      "A64": "discontinued(drug10)",
      "A65": "relaunched(drug10)",
      "G": "successful_treatment(drug1)"
    },
    "natural_facts": {
      "A1": "Organization1 uses substance1.",
      "A2": "Region1 has banned material1.",
      "A3": "Region1 has approved material1.",
      "A4": "Material1 is safe.",
      "A5": "Organization2 develops material2.",
      "A6": "Organization3 imports material2.",
      "A7": "Organization4 tests material2.",
      "A8": "Organization5 manufactures material2.",
      "A9": "Drug1 treats disease1.",
      "A10": "Drug1 is effective.",
      "A11": "Drug1 is in phase1 trial.",
      "A12": "Drug1 is in phase2 trial.",
      "A13": "Drug1 is in phase3 trial.",
      "A14": "Drug1 is FDA approved.",
      "A15": "Organization6 produces drug2.",
      "A16": "Organization6 is licensed.",
      "A17": "Organization7 imports drug2.",
      "A18": "Region2 has approved drug2.",
      "A19": "Drug2 is counterfeit.",
      "A20": "The FDA monitors drug3.",
      "A21": "The FDA investigates organization8.",
      "A22": "The FDA audits organization9.",
      "A23": "The FDA issued a warning letter to organization8.",
      "A24": "The FDA is conducting an inspection of organization9.",
      "A25": "Drug4 has side effects.",
      "A26": "Manufacturer1 recalls drug4.",
      "A27": "Drug4 is defective.",
      "A28": "Drug4 is contaminated.",
      "A29": "Patient1 filed a lawsuit against manufacturer1.",
      "A30": "Manufacturer1 settles lawsuit1.",
      "A31": "Manufacturer1 admits fault.",
      "A32": "Manufacturer1 denies fault.",
      "A33": "Drug5 is patented.",
      "A34": "A generic version of drug5 is available.",
      "A35": "Company1 extends the patent for drug5.",
      "A36": "Company2 competes with drug5.",
      "A37": "Company1 innovates drug6.",
      "A38": "Company1 acquires company3.",
      "A39": "Company1 researches disease2.",
      "A40": "Region3 has restricted material3.",
      "A41": "Company4 violates regulation1.",
      "A42": "Company4 is compliant.",
      "A43": "Company4 is fined.",
      "A44": "Agency1 investigates company4.",
      "A45": "Agency2 audits company4.",
      "A46": "Agency1 revokes the license of company4.",
      "A47": "Agency2 suspends the license of company4.",
      "A48": "Drug7 is an approved therapy.",
      "A49": "Drug7 is experimental.",
      "A50": "Insurance1 covers drug7.",
      "A51": "Drug7 is expensive.",
      "A52": "Medicare reimburses for drug7.",
      "A53": "The FDA rejected drug8.",
      "A54": "Company5 resubmits drug8.",
      "A55": "Company5 appeals decision1.",
      "A56": "Company5 litigates against the FDA.",
      "A57": "Company5 withdraws drug8.",
      "A58": "Company5 continues research on drug8.",
      "A59": "Company5 develops an alternative, drug9.",
      "A60": "Drug10 is profitable.",
      "A61": "Drug10 is successful.",
      "A62": "Drug10 is a blockbuster.",
      "A63": "Drug10 is niche.",
      "A64": "Drug10 is discontinued.",
      "A65": "Drug10 is relaunched.",
      "G": "Drug1 provides a successful treatment."
    },
    "prover9_expressions": [
      "(uses(organization1, substance1) | successful_treatment(drug1))",
      "(effective(drug1) -> (treats(drug1, disease1) -> successful_treatment(drug1)))",
      "(phase1_trial(drug1) -> effective(drug1))",
      "(phase1_trial(drug1) -> phase3_trial(drug1))",
      "(phase1_trial(drug1) | phase2_trial(drug1))",
      "(phase2_trial(drug1) -> effective(drug1))",
      "(phase3_trial(drug1) -> effective(drug1))",
      "(fda_approved(drug1) -> (phase3_trial(drug1) -> effective(drug1)))",
      "(produces(organization6, drug2) | successful_treatment(drug1))",
      "(licensed(organization6) -> produces(organization6, drug2))",
      "(licensed(organization6) | imports(organization7, drug2))",
      "(imports(organization7, drug2) -> approved(region2, drug2))",
      "(imports(organization7, drug2) -> successful_treatment(drug1))",
      "(approved(region2, drug2) -> successful_treatment(drug1))",
      "(banned(region1, material1) -> -uses(organization1, substance1))",
      "(monitors(fda, drug3) -> (-(imports(organization7, drug2) -> approved(region2, drug2)) -> counterfeit(drug2)))",
      "(investigates(fda, organization8) -> monitors(fda, drug3))",
      "(investigates(fda, organization8) | audits(fda, organization9))",
      "(audits(fda, organization9) -> monitors(fda, drug3))",
      "(warning_letter(fda, organization8) -> (audits(fda, organization9) -> monitors(fda, drug3)))",
      "(warning_letter(fda, organization8) | inspection(fda, organization9))",
      "(inspection(fda, organization9) -> (audits(fda, organization9) -> monitors(fda, drug3)))",
      "(recalls(manufacturer1, drug4) -> (-successful_treatment(drug1) -> -side_effects(drug4)))",
      "(contaminated(drug4) -> -defective(drug4))",
      "(settles(manufacturer1, lawsuit1) | (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1)))",
      "(admits_fault(manufacturer1) -> settles(manufacturer1, lawsuit1))",
      "(admits_fault(manufacturer1) | denies_fault(manufacturer1))",
      "(denies_fault(manufacturer1) -> (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1)))",
      "(patented(drug5) -> successful_treatment(drug1))",
      "(extends_patent(company1, drug5) -> (-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5)))",
      "(innovates(company1, drug6) -> (-extends_patent(company1, drug5) -> -competition(company2, drug5)))",
      "(innovates(company1, drug6) | acquires(company1, company3))",
      "(acquires(company1, company3) -> (-extends_patent(company1, drug5) -> -competition(company2, drug5)))",
      "(researches(company1, disease2) -> (innovates(company1, drug6) | acquires(company1, company3)))",
      "(restricted(region3, material3) -> -approved(region1, material1))",
      "(violates(company4, regulation1) -> compliant(company4))",
      "(violates(company4, regulation1) -> fined(company4))",
      "(violates(company4, regulation1) -> -compliant(company4))",
      "(fined(company4) -> -compliant(company4))",
      "(investigates(agency1, company4) -> (fined(company4) -> -compliant(company4)))",
      "(investigates(agency1, company4) | audits(agency2, company4))",
      "(audits(agency2, company4) -> (fined(company4) -> -compliant(company4)))",
      "(revokes_license(agency1, company4) -> (audits(agency2, company4) -> (fined(company4) -> -compliant(company4))))",
      "(revokes_license(agency1, company4) | suspends_license(agency2, company4))",
      "(suspends_license(agency2, company4) -> (audits(agency2, company4) -> (fined(company4) -> -compliant(company4))))",
      "(experimental(drug7) -> -approved_therapy(drug7))",
      "(develops(organization2, material2) -> (-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1)))",
      "(develops(organization2, material2) -> tests(organization4, material2))",
      "(develops(organization2, material2) | imports(organization3, material2))",
      "(expensive(drug7) -> -covered(insurance1, drug7))",
      "(reimbursed(medicare, drug7) | (-experimental(drug7) -> expensive(drug7)))",
      "(rejected(fda, drug8) -> -reimbursed(medicare, drug7))",
      "(resubmits(company5, drug8) -> (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1)))",
      "(appeals(company5, decision1) | (resubmits(company5, drug8) -> (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1))))",
      "(litigates(company5, fda) | (appeals(company5, decision1) | (resubmits(company5, drug8) -> (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1)))))",
      "(withdraws(company5, drug8) -> -litigates(company5, fda))",
      "(develops_alternative(company5, drug9) | (-withdraws(company5, drug8) -> -continues_research(company5, drug8)))",
      "(imports(organization3, material2) -> (-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1)))",
      "(successful(drug10) -> profitable(drug10))",
      "(blockbuster(drug10) -> successful(drug10))",
      "(relaunched(drug10) | (-(-(blockbuster(drug10) -> successful(drug10)) -> niche(drug10)) -> discontinued(drug10)))",
      "(tests(organization4, material2) -> (-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1)))",
      "(tests(organization4, material2) -> manufactures(organization5, material2))",
      "(manufactures(organization5, material2) -> (-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1)))",
      "(treats(drug1, disease1) -> successful_treatment(drug1))",
      "(-(imports(organization7, drug2) -> approved(region2, drug2)) -> counterfeit(drug2))",
      "(-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1))",
      "(-(contaminated(drug4) -> -defective(drug4)) -> -lawsuit(patient1, manufacturer1))",
      "(-(patented(drug5) -> successful_treatment(drug1)) -> generic_available(drug5))",
      "(-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5))",
      "(-(blockbuster(drug10) -> successful(drug10)) -> niche(drug10))",
      "(-(blockbuster(drug10) -> successful(drug10)) -> -niche(drug10))",
      "(-(-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5)) -> profitable(drug10))",
      "(-(-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5)) -> successful(drug10))",
      "(-(-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5)) -> blockbuster(drug10))",
      "(-(-(blockbuster(drug10) -> successful(drug10)) -> niche(drug10)) -> discontinued(drug10))",
      "(-(-banned(region1, material1) -> restricted(region3, material3)) -> violates(company4, regulation1))",
      "(-(-banned(region1, material1) -> -approved(region1, material1)) -> safe(material1))",
      "(-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1))",
      "(-effective(drug1) -> approved_therapy(drug7))",
      "(-banned(region1, material1) -> approved(region1, material1))",
      "(-banned(region1, material1) -> restricted(region3, material3))",
      "(-banned(region1, material1) -> -approved(region1, material1))",
      "(-recalls(manufacturer1, drug4) -> defective(drug4))",
      "(-recalls(manufacturer1, drug4) -> contaminated(drug4))",
      "(-recalls(manufacturer1, drug4) -> -defective(drug4))",
      "(-extends_patent(company1, drug5) -> competition(company2, drug5))",
      "(-extends_patent(company1, drug5) -> -competition(company2, drug5))",
      "(-experimental(drug7) -> covered(insurance1, drug7))",
      "(-experimental(drug7) -> expensive(drug7))",
      "(-experimental(drug7) -> -covered(insurance1, drug7))",
      "(-withdraws(company5, drug8) -> continues_research(company5, drug8))",
      "(-withdraws(company5, drug8) -> -continues_research(company5, drug8))",
      "(-successful_treatment(drug1) -> side_effects(drug4))",
      "(-successful_treatment(drug1) -> -side_effects(drug4))",
      "effective(drug1)",
      "fda_approved(drug1)",
      "banned(region1, material1)",
      "monitors(fda, drug3)",
      "recalls(manufacturer1, drug4)",
      "patented(drug5)",
      "extends_patent(company1, drug5)",
      "researches(company1, disease2)",
      "experimental(drug7)",
      "rejected(fda, drug8)",
      "resubmits(company5, drug8)",
      "withdraws(company5, drug8)",
      "treats(drug1, disease1)",
      "successful_treatment(drug1)",
      "-uses(organization1, substance1)",
      "-produces(organization6, drug2)",
      "-counterfeit(drug2)",
      "-settles(manufacturer1, lawsuit1)",
      "-violates(company4, regulation1)",
      "-approved_therapy(drug7)",
      "-reimbursed(medicare, drug7)",
      "-appeals(company5, decision1)",
      "-litigates(company5, fda)",
      "-develops_alternative(company5, drug9)",
      "-profitable(drug10)",
      "-discontinued(drug10)",
      "-relaunched(drug10)"
    ],
    "natural_expressions": [
      "Either organization1 uses substance1 or drug1 provides a successful treatment.",
      "Provided that drug1 is effective, then whenever drug1 treats disease1, it results in a successful treatment.",
      "If drug1 is in phase1 trial, then drug1 is effective.",
      "In case drug1 is in phase1 trial, then it is also in phase3 trial.",
      "Drug1 is in phase1 trial or drug1 is in phase2 trial.",
      "Whenever drug1 is in phase2 trial, it implies that drug1 is effective.",
      "Should drug1 be in phase3 trial, then drug1 is effective.",
      "Given that drug1 is FDA approved, then if drug1 is in phase3 trial, drug1 is effective.",
      "Either organization6 produces drug2 or drug1 provides a successful treatment.",
      "Provided that organization6 is licensed, then organization6 produces drug2.",
      "Organization6 is licensed or organization7 imports drug2.",
      "Whenever organization7 imports drug2, it follows that region2 has approved drug2.",
      "If organization7 imports drug2, then drug1 provides a successful treatment.",
      "In the event that region2 has approved drug2, then drug1 provides a successful treatment.",
      "Should region1 have banned material1, then organization1 does not use substance1.",
      "Whenever the FDA monitors drug3, then if it is not the case that imports by organization7 lead to approval by region2, drug2 is counterfeit.",
      "Provided that the FDA investigates organization8, then the FDA monitors drug3.",
      "The FDA investigates organization8 or the FDA audits organization9.",
      "In case the FDA audits organization9, then the FDA monitors drug3.",
      "Given that the FDA issued a warning letter to organization8, then whenever the FDA audits organization9, the FDA monitors drug3.",
      "Either the FDA issued a warning letter to organization8 or the FDA is conducting an inspection of organization9.",
      "Should the FDA be conducting an inspection of organization9, then if the FDA audits organization9, the FDA monitors drug3.",
      "Whenever manufacturer1 recalls drug4, then if drug1 does not provide a successful treatment, drug4 does not have side effects.",
      "Provided that drug4 is contaminated, then drug4 is not defective.",
      "Manufacturer1 settles lawsuit1 or, if it is not the case that contamination implies non-defectiveness, then patient1 filed a lawsuit against manufacturer1.",
      "In case manufacturer1 admits fault, then manufacturer1 settles lawsuit1.",
      "Manufacturer1 admits fault or manufacturer1 denies fault.",
      "Should manufacturer1 deny fault, then if contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1.",
      "Whenever drug5 is patented, then drug1 provides a successful treatment.",
      "Provided that company1 extends the patent for drug5, then if it is not the case that patenting leads to successful treatment, a generic version of drug5 is not available.",
      "In the event that company1 innovates drug6, then should company1 not extend the patent for drug5, company2 does not compete with drug5.",
      "Company1 innovates drug6 or company1 acquires company3.",
      "Whenever company1 acquires company3, then if company1 does not extend the patent for drug5, company2 does not compete with drug5.",
      "Provided that company1 researches disease2, then either company1 innovates drug6 or company1 acquires company3.",
      "In case region3 has restricted material3, then region1 has not approved material1.",
      "Should company4 violate regulation1, then company4 is compliant.",
      "Whenever company4 violates regulation1, then company4 is fined.",
      "Provided that company4 violates regulation1, then company4 is not compliant.",
      "In the event that company4 is fined, then company4 is not compliant.",
      "Given that agency1 investigates company4, then if company4 is fined, company4 is not compliant.",
      "Agency1 investigates company4 or agency2 audits company4.",
      "Should agency2 audit company4, then whenever company4 is fined, company4 is not compliant.",
      "Provided that agency1 revokes the license of company4, then if agency2 audits company4 and company4 is fined, company4 is not compliant.",
      "Either agency1 revokes the license of company4 or agency2 suspends the license of company4.",
      "In case agency2 suspends the license of company4, then if agency2 audits company4 and company4 is fined, company4 is not compliant.",
      "Whenever drug7 is experimental, then drug7 is not an approved therapy.",
      "Provided that organization2 develops material2, then if it is not the case that banning by region1 implies non-approval by region1, material1 is not safe.",
      "In the event that organization2 develops material2, then organization4 tests material2.",
      "Organization2 develops material2 or organization3 imports material2.",
      "Should drug7 be expensive, then insurance1 does not cover drug7.",
      "Medicare reimburses for drug7 or, if drug7 is not experimental, then drug7 is expensive.",
      "Provided that the FDA rejected drug8, then Medicare does not reimburse for drug7.",
      "Whenever company5 resubmits drug8, then if contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1.",
      "Company5 appeals decision1 or, should company5 resubmit drug8, then if contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1.",
      "Company5 litigates against the FDA or company5 appeals decision1 or, if company5 resubmits drug8, then whenever contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1.",
      "In case company5 withdraws drug8, then company5 does not litigate against the FDA.",
      "Company5 develops an alternative, drug9 or, provided that company5 does not withdraw drug8, then company5 does not continue research on drug8.",
      "Should organization3 import material2, then if it is not the case that banning by region1 implies non-approval by region1, material1 is not safe.",
      "Whenever drug10 is successful, then drug10 is profitable.",
      "Provided that drug10 is a blockbuster, then drug10 is successful.",
      "Drug10 is relaunched or, if it is not the case that blockbuster status implies success and then niche status, then drug10 is discontinued.",
      "In the event that organization4 tests material2, then should it not be the case that banning by region1 implies non-approval by region1, material1 is not safe.",
      "Provided that organization4 tests material2, then organization5 manufactures material2.",
      "Whenever organization5 manufactures material2, then if it is not the case that banning by region1 implies non-approval by region1, material1 is not safe.",
      "Should drug1 treat disease1, then drug1 provides a successful treatment.",
      "In case it is not true that imports by organization7 lead to approval by region2, then drug2 is counterfeit.",
      "Provided that contamination does not imply non-defectiveness, then patient1 filed a lawsuit against manufacturer1.",
      "Should contamination not imply non-defectiveness, then patient1 did not file a lawsuit against manufacturer1.",
      "Whenever it is not the case that patenting leads to successful treatment, then a generic version of drug5 is available.",
      "In the event that it is not true that patenting implies successful treatment, then a generic version of drug5 is not available.",
      "Provided that it is not the case that blockbuster status implies success, then drug10 is niche.",
      "Should it not be true that blockbuster status leads to success, then drug10 is not niche.",
      "In case it is not the case that non-patenting implies non-generic availability, then drug10 is profitable.",
      "Whenever it is not true that non-patenting leads to non-generic availability, then drug10 is successful.",
      "Provided that it is not the case that non-patenting implies non-generic availability, then drug10 is a blockbuster.",
      "Should it not be true that non-blockbuster status implies non-niche status, then drug10 is discontinued.",
      "In the event that it is not the case that non-banning by region1 leads to restriction by region3, then company4 violates regulation1.",
      "Provided that it is not true that non-banning implies non-approval by region1, then material1 is safe.",
      "Whenever it is not the case that non-banning leads to non-approval by region1, then material1 is not safe.",
      "Should drug1 not be effective, then drug7 is an approved therapy.",
      "In case region1 has not banned material1, then region1 has approved material1.",
      "Provided that region1 has not banned material1, then region3 has restricted material3.",
      "Whenever region1 has not banned material1, then region1 has not approved material1.",
      "Should manufacturer1 not recall drug4, then drug4 is defective.",
      "In the event that manufacturer1 does not recall drug4, then drug4 is contaminated.",
      "Provided that manufacturer1 does not recall drug4, then drug4 is not defective.",
      "Whenever company1 does not extend the patent for drug5, then company2 competes with drug5.",
      "In case company1 does not extend the patent for drug5, then company2 does not compete with drug5.",
      "Should drug7 not be experimental, then insurance1 covers drug7.",
      "Provided that drug7 is not experimental, then drug7 is expensive.",
      "Whenever drug7 is not experimental, then insurance1 does not cover drug7.",
      "In the event that company5 does not withdraw drug8, then company5 continues research on drug8.",
      "Should company5 not withdraw drug8, then company5 does not continue research on drug8.",
      "Provided that drug1 does not provide a successful treatment, then drug4 has side effects.",
      "Whenever drug1 does not provide a successful treatment, then drug4 does not have side effects.",
      "Drug1 is effective.",
      "Drug1 is FDA approved.",
      "Region1 has banned material1.",
      "The FDA monitors drug3.",
      "Manufacturer1 recalls drug4.",
      "Drug5 is patented.",
      "Company1 extends the patent for drug5.",
      "Company1 researches disease2.",
      "Drug7 is experimental.",
      "The FDA rejected drug8.",
      "Company5 resubmits drug8.",
      "Company5 withdraws drug8.",
      "Drug1 treats disease1.",
      "Drug1 provides a successful treatment.",
      "Organization1 does not use substance1.",
      "Organization6 does not produce drug2.",
      "Drug2 is not counterfeit.",
      "Manufacturer1 does not settle lawsuit1.",
      "Company4 does not violate regulation1.",
      "Drug7 is not an approved therapy.",
      "Medicare does not reimburse for drug7.",
      "Company5 does not appeal decision1.",
      "Company5 does not litigate against the FDA.",
      "Company5 does not develop an alternative, drug9.",
      "Drug10 is not profitable.",
      "Drug10 is not discontinued.",
      "Drug10 is not relaunched."
    ],
    "node_mappings": {
      "(A1 ∨ G)": {
        "formal": "(A1 ∨ G)",
        "prover9": "(A1 | G)",
        "prover9_expression": "(uses(organization1, substance1) | successful_treatment(drug1))",
        "natural": "Either organization1 uses substance1 or drug1 provides a successful treatment."
      },
      "(A10 → (A9 → G))": {
        "formal": "(A10 → (A9 → G))",
        "prover9": "(A10 -> (A9 -> G))",
        "prover9_expression": "(effective(drug1) -> (treats(drug1, disease1) -> successful_treatment(drug1)))",
        "natural": "Provided that drug1 is effective, then whenever drug1 treats disease1, it results in a successful treatment."
      },
      "(A11 → A10)": {
        "formal": "(A11 → A10)",
        "prover9": "(A11 -> A10)",
        "prover9_expression": "(phase1_trial(drug1) -> effective(drug1))",
        "natural": "If drug1 is in phase1 trial, then drug1 is effective."
      },
      "(A11 → A13)": {
        "formal": "(A11 → A13)",
        "prover9": "(A11 -> A13)",
        "prover9_expression": "(phase1_trial(drug1) -> phase3_trial(drug1))",
        "natural": "In case drug1 is in phase1 trial, then it is also in phase3 trial."
      },
      "(A11 ∨ A12)": {
        "formal": "(A11 ∨ A12)",
        "prover9": "(A11 | A12)",
        "prover9_expression": "(phase1_trial(drug1) | phase2_trial(drug1))",
        "natural": "Drug1 is in phase1 trial or drug1 is in phase2 trial."
      },
      "(A12 → A10)": {
        "formal": "(A12 → A10)",
        "prover9": "(A12 -> A10)",
        "prover9_expression": "(phase2_trial(drug1) -> effective(drug1))",
        "natural": "Whenever drug1 is in phase2 trial, it implies that drug1 is effective."
      },
      "(A13 → A10)": {
        "formal": "(A13 → A10)",
        "prover9": "(A13 -> A10)",
        "prover9_expression": "(phase3_trial(drug1) -> effective(drug1))",
        "natural": "Should drug1 be in phase3 trial, then drug1 is effective."
      },
      "(A14 → (A13 → A10))": {
        "formal": "(A14 → (A13 → A10))",
        "prover9": "(A14 -> (A13 -> A10))",
        "prover9_expression": "(fda_approved(drug1) -> (phase3_trial(drug1) -> effective(drug1)))",
        "natural": "Given that drug1 is FDA approved, then if drug1 is in phase3 trial, drug1 is effective."
      },
      "(A15 ∨ G)": {
        "formal": "(A15 ∨ G)",
        "prover9": "(A15 | G)",
        "prover9_expression": "(produces(organization6, drug2) | successful_treatment(drug1))",
        "natural": "Either organization6 produces drug2 or drug1 provides a successful treatment."
      },
      "(A16 → A15)": {
        "formal": "(A16 → A15)",
        "prover9": "(A16 -> A15)",
        "prover9_expression": "(licensed(organization6) -> produces(organization6, drug2))",
        "natural": "Provided that organization6 is licensed, then organization6 produces drug2."
      },
      "(A16 ∨ A17)": {
        "formal": "(A16 ∨ A17)",
        "prover9": "(A16 | A17)",
        "prover9_expression": "(licensed(organization6) | imports(organization7, drug2))",
        "natural": "Organization6 is licensed or organization7 imports drug2."
      },
      "(A17 → A18)": {
        "formal": "(A17 → A18)",
        "prover9": "(A17 -> A18)",
        "prover9_expression": "(imports(organization7, drug2) -> approved(region2, drug2))",
        "natural": "Whenever organization7 imports drug2, it follows that region2 has approved drug2."
      },
      "(A17 → G)": {
        "formal": "(A17 → G)",
        "prover9": "(A17 -> G)",
        "prover9_expression": "(imports(organization7, drug2) -> successful_treatment(drug1))",
        "natural": "If organization7 imports drug2, then drug1 provides a successful treatment."
      },
      "(A18 → G)": {
        "formal": "(A18 → G)",
        "prover9": "(A18 -> G)",
        "prover9_expression": "(approved(region2, drug2) -> successful_treatment(drug1))",
        "natural": "In the event that region2 has approved drug2, then drug1 provides a successful treatment."
      },
      "(A2 → ¬A1)": {
        "formal": "(A2 → ¬A1)",
        "prover9": "(A2 -> -A1)",
        "prover9_expression": "(banned(region1, material1) -> -uses(organization1, substance1))",
        "natural": "Should region1 have banned material1, then organization1 does not use substance1."
      },
      "(A20 → (¬(A17 → A18) → A19))": {
        "formal": "(A20 → (¬(A17 → A18) → A19))",
        "prover9": "(A20 -> (-(A17 -> A18) -> A19))",
        "prover9_expression": "(monitors(fda, drug3) -> (-(imports(organization7, drug2) -> approved(region2, drug2)) -> counterfeit(drug2)))",
        "natural": "Whenever the FDA monitors drug3, then if it is not the case that imports by organization7 lead to approval by region2, drug2 is counterfeit."
      },
      "(A21 → A20)": {
        "formal": "(A21 → A20)",
        "prover9": "(A21 -> A20)",
        "prover9_expression": "(investigates(fda, organization8) -> monitors(fda, drug3))",
        "natural": "Provided that the FDA investigates organization8, then the FDA monitors drug3."
      },
      "(A21 ∨ A22)": {
        "formal": "(A21 ∨ A22)",
        "prover9": "(A21 | A22)",
        "prover9_expression": "(investigates(fda, organization8) | audits(fda, organization9))",
        "natural": "The FDA investigates organization8 or the FDA audits organization9."
      },
      "(A22 → A20)": {
        "formal": "(A22 → A20)",
        "prover9": "(A22 -> A20)",
        "prover9_expression": "(audits(fda, organization9) -> monitors(fda, drug3))",
        "natural": "In case the FDA audits organization9, then the FDA monitors drug3."
      },
      "(A23 → (A22 → A20))": {
        "formal": "(A23 → (A22 → A20))",
        "prover9": "(A23 -> (A22 -> A20))",
        "prover9_expression": "(warning_letter(fda, organization8) -> (audits(fda, organization9) -> monitors(fda, drug3)))",
        "natural": "Given that the FDA issued a warning letter to organization8, then whenever the FDA audits organization9, the FDA monitors drug3."
      },
      "(A23 ∨ A24)": {
        "formal": "(A23 ∨ A24)",
        "prover9": "(A23 | A24)",
        "prover9_expression": "(warning_letter(fda, organization8) | inspection(fda, organization9))",
        "natural": "Either the FDA issued a warning letter to organization8 or the FDA is conducting an inspection of organization9."
      },
      "(A24 → (A22 → A20))": {
        "formal": "(A24 → (A22 → A20))",
        "prover9": "(A24 -> (A22 -> A20))",
        "prover9_expression": "(inspection(fda, organization9) -> (audits(fda, organization9) -> monitors(fda, drug3)))",
        "natural": "Should the FDA be conducting an inspection of organization9, then if the FDA audits organization9, the FDA monitors drug3."
      },
      "(A26 → (¬G → ¬A25))": {
        "formal": "(A26 → (¬G → ¬A25))",
        "prover9": "(A26 -> (-G -> -A25))",
        "prover9_expression": "(recalls(manufacturer1, drug4) -> (-successful_treatment(drug1) -> -side_effects(drug4)))",
        "natural": "Whenever manufacturer1 recalls drug4, then if drug1 does not provide a successful treatment, drug4 does not have side effects."
      },
      "(A28 → ¬A27)": {
        "formal": "(A28 → ¬A27)",
        "prover9": "(A28 -> -A27)",
        "prover9_expression": "(contaminated(drug4) -> -defective(drug4))",
        "natural": "Provided that drug4 is contaminated, then drug4 is not defective."
      },
      "(A30 ∨ (¬(A28 → ¬A27) → A29))": {
        "formal": "(A30 ∨ (¬(A28 → ¬A27) → A29))",
        "prover9": "(A30 | (-(A28 -> -A27) -> A29))",
        "prover9_expression": "(settles(manufacturer1, lawsuit1) | (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1)))",
        "natural": "Manufacturer1 settles lawsuit1 or, if it is not the case that contamination implies non-defectiveness, then patient1 filed a lawsuit against manufacturer1."
      },
      "(A31 → A30)": {
        "formal": "(A31 → A30)",
        "prover9": "(A31 -> A30)",
        "prover9_expression": "(admits_fault(manufacturer1) -> settles(manufacturer1, lawsuit1))",
        "natural": "In case manufacturer1 admits fault, then manufacturer1 settles lawsuit1."
      },
      "(A31 ∨ A32)": {
        "formal": "(A31 ∨ A32)",
        "prover9": "(A31 | A32)",
        "prover9_expression": "(admits_fault(manufacturer1) | denies_fault(manufacturer1))",
        "natural": "Manufacturer1 admits fault or manufacturer1 denies fault."
      },
      "(A32 → (¬(A28 → ¬A27) → A29))": {
        "formal": "(A32 → (¬(A28 → ¬A27) → A29))",
        "prover9": "(A32 -> (-(A28 -> -A27) -> A29))",
        "prover9_expression": "(denies_fault(manufacturer1) -> (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1)))",
        "natural": "Should manufacturer1 deny fault, then if contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1."
      },
      "(A33 → G)": {
        "formal": "(A33 → G)",
        "prover9": "(A33 -> G)",
        "prover9_expression": "(patented(drug5) -> successful_treatment(drug1))",
        "natural": "Whenever drug5 is patented, then drug1 provides a successful treatment."
      },
      "(A35 → (¬(A33 → G) → ¬A34))": {
        "formal": "(A35 → (¬(A33 → G) → ¬A34))",
        "prover9": "(A35 -> (-(A33 -> G) -> -A34))",
        "prover9_expression": "(extends_patent(company1, drug5) -> (-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5)))",
        "natural": "Provided that company1 extends the patent for drug5, then if it is not the case that patenting leads to successful treatment, a generic version of drug5 is not available."
      },
      "(A37 → (¬A35 → ¬A36))": {
        "formal": "(A37 → (¬A35 → ¬A36))",
        "prover9": "(A37 -> (-A35 -> -A36))",
        "prover9_expression": "(innovates(company1, drug6) -> (-extends_patent(company1, drug5) -> -competition(company2, drug5)))",
        "natural": "In the event that company1 innovates drug6, then should company1 not extend the patent for drug5, company2 does not compete with drug5."
      },
      "(A37 ∨ A38)": {
        "formal": "(A37 ∨ A38)",
        "prover9": "(A37 | A38)",
        "prover9_expression": "(innovates(company1, drug6) | acquires(company1, company3))",
        "natural": "Company1 innovates drug6 or company1 acquires company3."
      },
      "(A38 → (¬A35 → ¬A36))": {
        "formal": "(A38 → (¬A35 → ¬A36))",
        "prover9": "(A38 -> (-A35 -> -A36))",
        "prover9_expression": "(acquires(company1, company3) -> (-extends_patent(company1, drug5) -> -competition(company2, drug5)))",
        "natural": "Whenever company1 acquires company3, then if company1 does not extend the patent for drug5, company2 does not compete with drug5."
      },
      "(A39 → (A37 ∨ A38))": {
        "formal": "(A39 → (A37 ∨ A38))",
        "prover9": "(A39 -> (A37 | A38))",
        "prover9_expression": "(researches(company1, disease2) -> (innovates(company1, drug6) | acquires(company1, company3)))",
        "natural": "Provided that company1 researches disease2, then either company1 innovates drug6 or company1 acquires company3."
      },
      "(A40 → ¬A3)": {
        "formal": "(A40 → ¬A3)",
        "prover9": "(A40 -> -A3)",
        "prover9_expression": "(restricted(region3, material3) -> -approved(region1, material1))",
        "natural": "In case region3 has restricted material3, then region1 has not approved material1."
      },
      "(A41 → A42)": {
        "formal": "(A41 → A42)",
        "prover9": "(A41 -> A42)",
        "prover9_expression": "(violates(company4, regulation1) -> compliant(company4))",
        "natural": "Should company4 violate regulation1, then company4 is compliant."
      },
      "(A41 → A43)": {
        "formal": "(A41 → A43)",
        "prover9": "(A41 -> A43)",
        "prover9_expression": "(violates(company4, regulation1) -> fined(company4))",
        "natural": "Whenever company4 violates regulation1, then company4 is fined."
      },
      "(A41 → ¬A42)": {
        "formal": "(A41 → ¬A42)",
        "prover9": "(A41 -> -A42)",
        "prover9_expression": "(violates(company4, regulation1) -> -compliant(company4))",
        "natural": "Provided that company4 violates regulation1, then company4 is not compliant."
      },
      "(A43 → ¬A42)": {
        "formal": "(A43 → ¬A42)",
        "prover9": "(A43 -> -A42)",
        "prover9_expression": "(fined(company4) -> -compliant(company4))",
        "natural": "In the event that company4 is fined, then company4 is not compliant."
      },
      "(A44 → (A43 → ¬A42))": {
        "formal": "(A44 → (A43 → ¬A42))",
        "prover9": "(A44 -> (A43 -> -A42))",
        "prover9_expression": "(investigates(agency1, company4) -> (fined(company4) -> -compliant(company4)))",
        "natural": "Given that agency1 investigates company4, then if company4 is fined, company4 is not compliant."
      },
      "(A44 ∨ A45)": {
        "formal": "(A44 ∨ A45)",
        "prover9": "(A44 | A45)",
        "prover9_expression": "(investigates(agency1, company4) | audits(agency2, company4))",
        "natural": "Agency1 investigates company4 or agency2 audits company4."
      },
      "(A45 → (A43 → ¬A42))": {
        "formal": "(A45 → (A43 → ¬A42))",
        "prover9": "(A45 -> (A43 -> -A42))",
        "prover9_expression": "(audits(agency2, company4) -> (fined(company4) -> -compliant(company4)))",
        "natural": "Should agency2 audit company4, then whenever company4 is fined, company4 is not compliant."
      },
      "(A46 → (A45 → (A43 → ¬A42)))": {
        "formal": "(A46 → (A45 → (A43 → ¬A42)))",
        "prover9": "(A46 -> (A45 -> (A43 -> -A42)))",
        "prover9_expression": "(revokes_license(agency1, company4) -> (audits(agency2, company4) -> (fined(company4) -> -compliant(company4))))",
        "natural": "Provided that agency1 revokes the license of company4, then if agency2 audits company4 and company4 is fined, company4 is not compliant."
      },
      "(A46 ∨ A47)": {
        "formal": "(A46 ∨ A47)",
        "prover9": "(A46 | A47)",
        "prover9_expression": "(revokes_license(agency1, company4) | suspends_license(agency2, company4))",
        "natural": "Either agency1 revokes the license of company4 or agency2 suspends the license of company4."
      },
      "(A47 → (A45 → (A43 → ¬A42)))": {
        "formal": "(A47 → (A45 → (A43 → ¬A42)))",
        "prover9": "(A47 -> (A45 -> (A43 -> -A42)))",
        "prover9_expression": "(suspends_license(agency2, company4) -> (audits(agency2, company4) -> (fined(company4) -> -compliant(company4))))",
        "natural": "In case agency2 suspends the license of company4, then if agency2 audits company4 and company4 is fined, company4 is not compliant."
      },
      "(A49 → ¬A48)": {
        "formal": "(A49 → ¬A48)",
        "prover9": "(A49 -> -A48)",
        "prover9_expression": "(experimental(drug7) -> -approved_therapy(drug7))",
        "natural": "Whenever drug7 is experimental, then drug7 is not an approved therapy."
      },
      "(A5 → (¬(¬A2 → ¬A3) → ¬A4))": {
        "formal": "(A5 → (¬(¬A2 → ¬A3) → ¬A4))",
        "prover9": "(A5 -> (-(-A2 -> -A3) -> -A4))",
        "prover9_expression": "(develops(organization2, material2) -> (-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1)))",
        "natural": "Provided that organization2 develops material2, then if it is not the case that banning by region1 implies non-approval by region1, material1 is not safe."
      },
      "(A5 → A7)": {
        "formal": "(A5 → A7)",
        "prover9": "(A5 -> A7)",
        "prover9_expression": "(develops(organization2, material2) -> tests(organization4, material2))",
        "natural": "In the event that organization2 develops material2, then organization4 tests material2."
      },
      "(A5 ∨ A6)": {
        "formal": "(A5 ∨ A6)",
        "prover9": "(A5 | A6)",
        "prover9_expression": "(develops(organization2, material2) | imports(organization3, material2))",
        "natural": "Organization2 develops material2 or organization3 imports material2."
      },
      "(A51 → ¬A50)": {
        "formal": "(A51 → ¬A50)",
        "prover9": "(A51 -> -A50)",
        "prover9_expression": "(expensive(drug7) -> -covered(insurance1, drug7))",
        "natural": "Should drug7 be expensive, then insurance1 does not cover drug7."
      },
      "(A52 ∨ (¬A49 → A51))": {
        "formal": "(A52 ∨ (¬A49 → A51))",
        "prover9": "(A52 | (-A49 -> A51))",
        "prover9_expression": "(reimbursed(medicare, drug7) | (-experimental(drug7) -> expensive(drug7)))",
        "natural": "Medicare reimburses for drug7 or, if drug7 is not experimental, then drug7 is expensive."
      },
      "(A53 → ¬A52)": {
        "formal": "(A53 → ¬A52)",
        "prover9": "(A53 -> -A52)",
        "prover9_expression": "(rejected(fda, drug8) -> -reimbursed(medicare, drug7))",
        "natural": "Provided that the FDA rejected drug8, then Medicare does not reimburse for drug7."
      },
      "(A54 → (¬(A28 → ¬A27) → A29))": {
        "formal": "(A54 → (¬(A28 → ¬A27) → A29))",
        "prover9": "(A54 -> (-(A28 -> -A27) -> A29))",
        "prover9_expression": "(resubmits(company5, drug8) -> (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1)))",
        "natural": "Whenever company5 resubmits drug8, then if contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1."
      },
      "(A55 ∨ (A54 → (¬(A28 → ¬A27) → A29)))": {
        "formal": "(A55 ∨ (A54 → (¬(A28 → ¬A27) → A29)))",
        "prover9": "(A55 | (A54 -> (-(A28 -> -A27) -> A29)))",
        "prover9_expression": "(appeals(company5, decision1) | (resubmits(company5, drug8) -> (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1))))",
        "natural": "Company5 appeals decision1 or, should company5 resubmit drug8, then if contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1."
      },
      "(A56 ∨ (A55 ∨ (A54 → (¬(A28 → ¬A27) → A29))))": {
        "formal": "(A56 ∨ (A55 ∨ (A54 → (¬(A28 → ¬A27) → A29))))",
        "prover9": "(A56 | (A55 | (A54 -> (-(A28 -> -A27) -> A29))))",
        "prover9_expression": "(litigates(company5, fda) | (appeals(company5, decision1) | (resubmits(company5, drug8) -> (-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1)))))",
        "natural": "Company5 litigates against the FDA or company5 appeals decision1 or, if company5 resubmits drug8, then whenever contamination does not imply non-defectiveness, patient1 filed a lawsuit against manufacturer1."
      },
      "(A57 → ¬A56)": {
        "formal": "(A57 → ¬A56)",
        "prover9": "(A57 -> -A56)",
        "prover9_expression": "(withdraws(company5, drug8) -> -litigates(company5, fda))",
        "natural": "In case company5 withdraws drug8, then company5 does not litigate against the FDA."
      },
      "(A59 ∨ (¬A57 → ¬A58))": {
        "formal": "(A59 ∨ (¬A57 → ¬A58))",
        "prover9": "(A59 | (-A57 -> -A58))",
        "prover9_expression": "(develops_alternative(company5, drug9) | (-withdraws(company5, drug8) -> -continues_research(company5, drug8)))",
        "natural": "Company5 develops an alternative, drug9 or, provided that company5 does not withdraw drug8, then company5 does not continue research on drug8."
      },
      "(A6 → (¬(¬A2 → ¬A3) → ¬A4))": {
        "formal": "(A6 → (¬(¬A2 → ¬A3) → ¬A4))",
        "prover9": "(A6 -> (-(-A2 -> -A3) -> -A4))",
        "prover9_expression": "(imports(organization3, material2) -> (-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1)))",
        "natural": "Should organization3 import material2, then if it is not the case that banning by region1 implies non-approval by region1, material1 is not safe."
      },
      "(A61 → A60)": {
        "formal": "(A61 → A60)",
        "prover9": "(A61 -> A60)",
        "prover9_expression": "(successful(drug10) -> profitable(drug10))",
        "natural": "Whenever drug10 is successful, then drug10 is profitable."
      },
      "(A62 → A61)": {
        "formal": "(A62 → A61)",
        "prover9": "(A62 -> A61)",
        "prover9_expression": "(blockbuster(drug10) -> successful(drug10))",
        "natural": "Provided that drug10 is a blockbuster, then drug10 is successful."
      },
      "(A65 ∨ (¬(¬(A62 → A61) → A63) → A64))": {
        "formal": "(A65 ∨ (¬(¬(A62 → A61) → A63) → A64))",
        "prover9": "(A65 | (-(-(A62 -> A61) -> A63) -> A64))",
        "prover9_expression": "(relaunched(drug10) | (-(-(blockbuster(drug10) -> successful(drug10)) -> niche(drug10)) -> discontinued(drug10)))",
        "natural": "Drug10 is relaunched or, if it is not the case that blockbuster status implies success and then niche status, then drug10 is discontinued."
      },
      "(A7 → (¬(¬A2 → ¬A3) → ¬A4))": {
        "formal": "(A7 → (¬(¬A2 → ¬A3) → ¬A4))",
        "prover9": "(A7 -> (-(-A2 -> -A3) -> -A4))",
        "prover9_expression": "(tests(organization4, material2) -> (-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1)))",
        "natural": "In the event that organization4 tests material2, then should it not be the case that banning by region1 implies non-approval by region1, material1 is not safe."
      },
      "(A7 → A8)": {
        "formal": "(A7 → A8)",
        "prover9": "(A7 -> A8)",
        "prover9_expression": "(tests(organization4, material2) -> manufactures(organization5, material2))",
        "natural": "Provided that organization4 tests material2, then organization5 manufactures material2."
      },
      "(A8 → (¬(¬A2 → ¬A3) → ¬A4))": {
        "formal": "(A8 → (¬(¬A2 → ¬A3) → ¬A4))",
        "prover9": "(A8 -> (-(-A2 -> -A3) -> -A4))",
        "prover9_expression": "(manufactures(organization5, material2) -> (-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1)))",
        "natural": "Whenever organization5 manufactures material2, then if it is not the case that banning by region1 implies non-approval by region1, material1 is not safe."
      },
      "(A9 → G)": {
        "formal": "(A9 → G)",
        "prover9": "(A9 -> G)",
        "prover9_expression": "(treats(drug1, disease1) -> successful_treatment(drug1))",
        "natural": "Should drug1 treat disease1, then drug1 provides a successful treatment."
      },
      "(¬(A17 → A18) → A19)": {
        "formal": "(¬(A17 → A18) → A19)",
        "prover9": "(-(A17 -> A18) -> A19)",
        "prover9_expression": "(-(imports(organization7, drug2) -> approved(region2, drug2)) -> counterfeit(drug2))",
        "natural": "In case it is not true that imports by organization7 lead to approval by region2, then drug2 is counterfeit."
      },
      "(¬(A28 → ¬A27) → A29)": {
        "formal": "(¬(A28 → ¬A27) → A29)",
        "prover9": "(-(A28 -> -A27) -> A29)",
        "prover9_expression": "(-(contaminated(drug4) -> -defective(drug4)) -> lawsuit(patient1, manufacturer1))",
        "natural": "Provided that contamination does not imply non-defectiveness, then patient1 filed a lawsuit against manufacturer1."
      },
      "(¬(A28 → ¬A27) → ¬A29)": {
        "formal": "(¬(A28 → ¬A27) → ¬A29)",
        "prover9": "(-(A28 -> -A27) -> -A29)",
        "prover9_expression": "(-(contaminated(drug4) -> -defective(drug4)) -> -lawsuit(patient1, manufacturer1))",
        "natural": "Should contamination not imply non-defectiveness, then patient1 did not file a lawsuit against manufacturer1."
      },
      "(¬(A33 → G) → A34)": {
        "formal": "(¬(A33 → G) → A34)",
        "prover9": "(-(A33 -> G) -> A34)",
        "prover9_expression": "(-(patented(drug5) -> successful_treatment(drug1)) -> generic_available(drug5))",
        "natural": "Whenever it is not the case that patenting leads to successful treatment, then a generic version of drug5 is available."
      },
      "(¬(A33 → G) → ¬A34)": {
        "formal": "(¬(A33 → G) → ¬A34)",
        "prover9": "(-(A33 -> G) -> -A34)",
        "prover9_expression": "(-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5))",
        "natural": "In the event that it is not true that patenting implies successful treatment, then a generic version of drug5 is not available."
      },
      "(¬(A62 → A61) → A63)": {
        "formal": "(¬(A62 → A61) → A63)",
        "prover9": "(-(A62 -> A61) -> A63)",
        "prover9_expression": "(-(blockbuster(drug10) -> successful(drug10)) -> niche(drug10))",
        "natural": "Provided that it is not the case that blockbuster status implies success, then drug10 is niche."
      },
      "(¬(A62 → A61) → ¬A63)": {
        "formal": "(¬(A62 → A61) → ¬A63)",
        "prover9": "(-(A62 -> A61) -> -A63)",
        "prover9_expression": "(-(blockbuster(drug10) -> successful(drug10)) -> -niche(drug10))",
        "natural": "Should it not be true that blockbuster status leads to success, then drug10 is not niche."
      },
      "(¬(¬(A33 → G) → ¬A34) → A60)": {
        "formal": "(¬(¬(A33 → G) → ¬A34) → A60)",
        "prover9": "(-(-(A33 -> G) -> -A34) -> A60)",
        "prover9_expression": "(-(-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5)) -> profitable(drug10))",
        "natural": "In case it is not the case that non-patenting implies non-generic availability, then drug10 is profitable."
      },
      "(¬(¬(A33 → G) → ¬A34) → A61)": {
        "formal": "(¬(¬(A33 → G) → ¬A34) → A61)",
        "prover9": "(-(-(A33 -> G) -> -A34) -> A61)",
        "prover9_expression": "(-(-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5)) -> successful(drug10))",
        "natural": "Whenever it is not true that non-patenting leads to non-generic availability, then drug10 is successful."
      },
      "(¬(¬(A33 → G) → ¬A34) → A62)": {
        "formal": "(¬(¬(A33 → G) → ¬A34) → A62)",
        "prover9": "(-(-(A33 -> G) -> -A34) -> A62)",
        "prover9_expression": "(-(-(patented(drug5) -> successful_treatment(drug1)) -> -generic_available(drug5)) -> blockbuster(drug10))",
        "natural": "Provided that it is not the case that non-patenting implies non-generic availability, then drug10 is a blockbuster."
      },
      "(¬(¬(A62 → A61) → A63) → A64)": {
        "formal": "(¬(¬(A62 → A61) → A63) → A64)",
        "prover9": "(-(-(A62 -> A61) -> A63) -> A64)",
        "prover9_expression": "(-(-(blockbuster(drug10) -> successful(drug10)) -> niche(drug10)) -> discontinued(drug10))",
        "natural": "Should it not be true that non-blockbuster status implies non-niche status, then drug10 is discontinued."
      },
      "(¬(¬A2 → A40) → A41)": {
        "formal": "(¬(¬A2 → A40) → A41)",
        "prover9": "(-(-A2 -> A40) -> A41)",
        "prover9_expression": "(-(-banned(region1, material1) -> restricted(region3, material3)) -> violates(company4, regulation1))",
        "natural": "In the event that it is not the case that non-banning by region1 leads to restriction by region3, then company4 violates regulation1."
      },
      "(¬(¬A2 → ¬A3) → A4)": {
        "formal": "(¬(¬A2 → ¬A3) → A4)",
        "prover9": "(-(-A2 -> -A3) -> A4)",
        "prover9_expression": "(-(-banned(region1, material1) -> -approved(region1, material1)) -> safe(material1))",
        "natural": "Provided that it is not true that non-banning implies non-approval by region1, then material1 is safe."
      },
      "(¬(¬A2 → ¬A3) → ¬A4)": {
        "formal": "(¬(¬A2 → ¬A3) → ¬A4)",
        "prover9": "(-(-A2 -> -A3) -> -A4)",
        "prover9_expression": "(-(-banned(region1, material1) -> -approved(region1, material1)) -> -safe(material1))",
        "natural": "Whenever it is not the case that non-banning leads to non-approval by region1, then material1 is not safe."
      },
      "(¬A10 → A48)": {
        "formal": "(¬A10 → A48)",
        "prover9": "(-A10 -> A48)",
        "prover9_expression": "(-effective(drug1) -> approved_therapy(drug7))",
        "natural": "Should drug1 not be effective, then drug7 is an approved therapy."
      },
      "(¬A2 → A3)": {
        "formal": "(¬A2 → A3)",
        "prover9": "(-A2 -> A3)",
        "prover9_expression": "(-banned(region1, material1) -> approved(region1, material1))",
        "natural": "In case region1 has not banned material1, then region1 has approved material1."
      },
      "(¬A2 → A40)": {
        "formal": "(¬A2 → A40)",
        "prover9": "(-A2 -> A40)",
        "prover9_expression": "(-banned(region1, material1) -> restricted(region3, material3))",
        "natural": "Provided that region1 has not banned material1, then region3 has restricted material3."
      },
      "(¬A2 → ¬A3)": {
        "formal": "(¬A2 → ¬A3)",
        "prover9": "(-A2 -> -A3)",
        "prover9_expression": "(-banned(region1, material1) -> -approved(region1, material1))",
        "natural": "Whenever region1 has not banned material1, then region1 has not approved material1."
      },
      "(¬A26 → A27)": {
        "formal": "(¬A26 → A27)",
        "prover9": "(-A26 -> A27)",
        "prover9_expression": "(-recalls(manufacturer1, drug4) -> defective(drug4))",
        "natural": "Should manufacturer1 not recall drug4, then drug4 is defective."
      },
      "(¬A26 → A28)": {
        "formal": "(¬A26 → A28)",
        "prover9": "(-A26 -> A28)",
        "prover9_expression": "(-recalls(manufacturer1, drug4) -> contaminated(drug4))",
        "natural": "In the event that manufacturer1 does not recall drug4, then drug4 is contaminated."
      },
      "(¬A26 → ¬A27)": {
        "formal": "(¬A26 → ¬A27)",
        "prover9": "(-A26 -> -A27)",
        "prover9_expression": "(-recalls(manufacturer1, drug4) -> -defective(drug4))",
        "natural": "Provided that manufacturer1 does not recall drug4, then drug4 is not defective."
      },
      "(¬A35 → A36)": {
        "formal": "(¬A35 → A36)",
        "prover9": "(-A35 -> A36)",
        "prover9_expression": "(-extends_patent(company1, drug5) -> competition(company2, drug5))",
        "natural": "Whenever company1 does not extend the patent for drug5, then company2 competes with drug5."
      },
      "(¬A35 → ¬A36)": {
        "formal": "(¬A35 → ¬A36)",
        "prover9": "(-A35 -> -A36)",
        "prover9_expression": "(-extends_patent(company1, drug5) -> -competition(company2, drug5))",
        "natural": "In case company1 does not extend the patent for drug5, then company2 does not compete with drug5."
      },
      "(¬A49 → A50)": {
        "formal": "(¬A49 → A50)",
        "prover9": "(-A49 -> A50)",
        "prover9_expression": "(-experimental(drug7) -> covered(insurance1, drug7))",
        "natural": "Should drug7 not be experimental, then insurance1 covers drug7."
      },
      "(¬A49 → A51)": {
        "formal": "(¬A49 → A51)",
        "prover9": "(-A49 -> A51)",
        "prover9_expression": "(-experimental(drug7) -> expensive(drug7))",
        "natural": "Provided that drug7 is not experimental, then drug7 is expensive."
      },
      "(¬A49 → ¬A50)": {
        "formal": "(¬A49 → ¬A50)",
        "prover9": "(-A49 -> -A50)",
        "prover9_expression": "(-experimental(drug7) -> -covered(insurance1, drug7))",
        "natural": "Whenever drug7 is not experimental, then insurance1 does not cover drug7."
      },
      "(¬A57 → A58)": {
        "formal": "(¬A57 → A58)",
        "prover9": "(-A57 -> A58)",
        "prover9_expression": "(-withdraws(company5, drug8) -> continues_research(company5, drug8))",
        "natural": "In the event that company5 does not withdraw drug8, then company5 continues research on drug8."
      },
      "(¬A57 → ¬A58)": {
        "formal": "(¬A57 → ¬A58)",
        "prover9": "(-A57 -> -A58)",
        "prover9_expression": "(-withdraws(company5, drug8) -> -continues_research(company5, drug8))",
        "natural": "Should company5 not withdraw drug8, then company5 does not continue research on drug8."
      },
      "(¬G → A25)": {
        "formal": "(¬G → A25)",
        "prover9": "(-G -> A25)",
        "prover9_expression": "(-successful_treatment(drug1) -> side_effects(drug4))",
        "natural": "Provided that drug1 does not provide a successful treatment, then drug4 has side effects."
      },
      "(¬G → ¬A25)": {
        "formal": "(¬G → ¬A25)",
        "prover9": "(-G -> -A25)",
        "prover9_expression": "(-successful_treatment(drug1) -> -side_effects(drug4))",
        "natural": "Whenever drug1 does not provide a successful treatment, then drug4 does not have side effects."
      },
      "A10": {
        "formal": "A10",
        "prover9": "A10",
        "prover9_expression": "effective(drug1)",
        "natural": "Drug1 is effective."
      },
      "A14": {
        "formal": "A14",
        "prover9": "A14",
        "prover9_expression": "fda_approved(drug1)",
        "natural": "Drug1 is FDA approved."
      },
      "A2": {
        "formal": "A2",
        "prover9": "A2",
        "prover9_expression": "banned(region1, material1)",
        "natural": "Region1 has banned material1."
      },
      "A20": {
        "formal": "A20",
        "prover9": "A20",
        "prover9_expression": "monitors(fda, drug3)",
        "natural": "The FDA monitors drug3."
      },
      "A26": {
        "formal": "A26",
        "prover9": "A26",
        "prover9_expression": "recalls(manufacturer1, drug4)",
        "natural": "Manufacturer1 recalls drug4."
      },
      "A33": {
        "formal": "A33",
        "prover9": "A33",
        "prover9_expression": "patented(drug5)",
        "natural": "Drug5 is patented."
      },
      "A35": {
        "formal": "A35",
        "prover9": "A35",
        "prover9_expression": "extends_patent(company1, drug5)",
        "natural": "Company1 extends the patent for drug5."
      },
      "A39": {
        "formal": "A39",
        "prover9": "A39",
        "prover9_expression": "researches(company1, disease2)",
        "natural": "Company1 researches disease2."
      },
      "A49": {
        "formal": "A49",
        "prover9": "A49",
        "prover9_expression": "experimental(drug7)",
        "natural": "Drug7 is experimental."
      },
      "A53": {
        "formal": "A53",
        "prover9": "A53",
        "prover9_expression": "rejected(fda, drug8)",
        "natural": "The FDA rejected drug8."
      },
      "A54": {
        "formal": "A54",
        "prover9": "A54",
        "prover9_expression": "resubmits(company5, drug8)",
        "natural": "Company5 resubmits drug8."
      },
      "A57": {
        "formal": "A57",
        "prover9": "A57",
        "prover9_expression": "withdraws(company5, drug8)",
        "natural": "Company5 withdraws drug8."
      },
      "A9": {
        "formal": "A9",
        "prover9": "A9",
        "prover9_expression": "treats(drug1, disease1)",
        "natural": "Drug1 treats disease1."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "successful_treatment(drug1)",
        "natural": "Drug1 provides a successful treatment."
      },
      "¬A1": {
        "formal": "¬A1",
        "prover9": "-A1",
        "prover9_expression": "-uses(organization1, substance1)",
        "natural": "Organization1 does not use substance1."
      },
      "¬A15": {
        "formal": "¬A15",
        "prover9": "-A15",
        "prover9_expression": "-produces(organization6, drug2)",
        "natural": "Organization6 does not produce drug2."
      },
      "¬A19": {
        "formal": "¬A19",
        "prover9": "-A19",
        "prover9_expression": "-counterfeit(drug2)",
        "natural": "Drug2 is not counterfeit."
      },
      "¬A30": {
        "formal": "¬A30",
        "prover9": "-A30",
        "prover9_expression": "-settles(manufacturer1, lawsuit1)",
        "natural": "Manufacturer1 does not settle lawsuit1."
      },
      "¬A41": {
        "formal": "¬A41",
        "prover9": "-A41",
        "prover9_expression": "-violates(company4, regulation1)",
        "natural": "Company4 does not violate regulation1."
      },
      "¬A48": {
        "formal": "¬A48",
        "prover9": "-A48",
        "prover9_expression": "-approved_therapy(drug7)",
        "natural": "Drug7 is not an approved therapy."
      },
      "¬A52": {
        "formal": "¬A52",
        "prover9": "-A52",
        "prover9_expression": "-reimbursed(medicare, drug7)",
        "natural": "Medicare does not reimburse for drug7."
      },
      "¬A55": {
        "formal": "¬A55",
        "prover9": "-A55",
        "prover9_expression": "-appeals(company5, decision1)",
        "natural": "Company5 does not appeal decision1."
      },
      "¬A56": {
        "formal": "¬A56",
        "prover9": "-A56",
        "prover9_expression": "-litigates(company5, fda)",
        "natural": "Company5 does not litigate against the FDA."
      },
      "¬A59": {
        "formal": "¬A59",
        "prover9": "-A59",
        "prover9_expression": "-develops_alternative(company5, drug9)",
        "natural": "Company5 does not develop an alternative, drug9."
      },
      "¬A60": {
        "formal": "¬A60",
        "prover9": "-A60",
        "prover9_expression": "-profitable(drug10)",
        "natural": "Drug10 is not profitable."
      },
      "¬A64": {
        "formal": "¬A64",
        "prover9": "-A64",
        "prover9_expression": "-discontinued(drug10)",
        "natural": "Drug10 is not discontinued."
      },
      "¬A65": {
        "formal": "¬A65",
        "prover9": "-A65",
        "prover9_expression": "-relaunched(drug10)",
        "natural": "Drug10 is not relaunched."
      }
    }
  }
}